Diabetic Gastroparesis Clinical Trial
Official title:
The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.
At least 44 subjects who meet all the inclusion criteria but do not meet any exclusion criteria will be enrolled in this study. Data of demographic characteristics, Gastroparesis Cardinal Symptom Index (GCSI), Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM), Gastroparesis Core Symptom Daily Diary (GCS-DD), Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QoL), and clinical outcomes will be collected. After treatment, they will enter the follow-up period for efficacy and safety evaluation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01557296 -
Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
|
Phase 2 | |
Withdrawn |
NCT03376399 -
Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
|
||
Not yet recruiting |
NCT02264587 -
Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis
|
Phase 4 | |
Completed |
NCT02289846 -
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
|
Phase 2 | |
Completed |
NCT03544229 -
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
|
Phase 2 | |
Recruiting |
NCT04706832 -
Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study
|
N/A | |
Not yet recruiting |
NCT05584462 -
Gastroparesis in type2 Diabetic Patient
|
||
Enrolling by invitation |
NCT05812339 -
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
|
||
Completed |
NCT02732821 -
G-POEM for Treatment of Refractory Gastroparesis
|
||
Completed |
NCT01030341 -
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
|
N/A | |
Recruiting |
NCT05832151 -
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
|
Phase 2 | |
Completed |
NCT02025725 -
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis
|
Phase 3 | |
Completed |
NCT01916460 -
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients
|
N/A | |
Completed |
NCT01469286 -
Transcutaneous Electroacupuncture for Gastroparesis
|
Phase 1 | |
Terminated |
NCT00874133 -
The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis
|
N/A | |
Completed |
NCT01126034 -
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
|
N/A | |
Recruiting |
NCT05273788 -
Thoracic Neuromodulation for Diabetic Gastroparesis
|
N/A | |
Suspended |
NCT00470795 -
Acupuncture for Diabetic Gastroparesis
|
Phase 3 | |
Completed |
NCT00139893 -
A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis
|
N/A | |
Recruiting |
NCT04254549 -
Rifaximin in Patients With Diabetic Gastroparesis
|
Phase 2 |